Ebola Vaccine's Success will Lead to Award for Iowa Company

Photo: MGNonline.

December 24, 2016 02:48 PM

DES MOINES, Iowa (AP) - A vaccine that an Iowa company helped develop is expected to stop one of the world's deadliest viruses.

The Des Moines Register reports that a study published Thursday shows the vaccine is 100 percent effective in protecting people against Ebola, an infectious virus that has killed thousands and traumatized millions.


Ames-based NewLink Genetics helped test and refine an Ebola vaccine that was invented by Canadian scientists. A study in the British medical journal The Lancet says the shots protect people who might have come in contact with an infected person.

Thomas Monath, NewLink's chief scientific officer for infectious diseases, says the vaccine's success should mean the world will never see another widespread Ebola epidemic.

Besides royalties, the company could share in a reward offered by the U.S. government.

(Copyright 2016 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)


(Copyright 2016 by The Associated Press. All Rights Reserved.)


Most Read Stories

Eyota Volunteer Ambulance Service Recognized for their Innovative Work
Over 250 Minnesota Residents Apply to Set Legislators' Pay
Iowa Doctor to Pay $5,000 Fine, Refrain from Surgery
University of Minnesota Captures Transgender Experiences
Ebola Vaccine's Success will Lead to Award for Iowa Company
School Resource Officer Helps Provide Gift of Music to Kids
Northern Iowa Woman Killed in Highway Crash near Blairsburg
NORAD: Santa Is On His Way